Drugs for the Treatment of Respiratory Diseases

Part I. Asthma and COPD: 1. Pathology of asthma and COPD Peter K. Jeffery; 2. Glucocorticosteroids Peter J. Barnes; 3. ß2- adrenoceptor agonists Domenico Spina, Clive P. Page and Brian J. O'Connor; 4. Anticholinergic bronchodilators Jeremy M. Segal and Nicholas J. Gross; 5. Antiallergic drugs Mazakazu Ichinose; 6. Drugs affecting the synthesis and action of leukotrienes Paul M. O'Byrne; 7. Theophylline and selective phosphodiesterase inhibitors in the treatment of respiratory disease N. A. Jones, Domenico Spina and Clive P. Page; 8. Potential therapeutic effects of potassium channel openers in respiratory diseases Ahmed Z. El-Hashim; 9. Tachykinin and kinin antagonists Pierangelo Geppetti; 10. Drugs affecting IgE (synthesis inhibitors and monoclonal antibodies) Lawrence G. Garland and Alan G. Lamont; 11. Drugs targeting cell signalling Brydon L. Bennett, Yoshitaka Satoh and Alan J. Lewis; Part II. Diffuse Parenchymal Lung Disease: 12. Current approaches to the treatment of parenchymal lung diseases Joseph P. Lynch III and Michael Keane; 13. Drug treatments of the future in fibrotic lung disease Athol U. Wells; Part III. Infection: 14. Current and future management of pneumonia Mario Cazzola and Maria G. Matera; 15. Current treatment of chronic bronchial suppuration Robert Wilson; 16. Current and future treatment of cystic fibrosis R. Gary, G. Ruiz, Hilary Wyatt and John F. Price; Part IV. Pulmonary Vascular Diseases: 17. Pathophysiology of pulmonary vascular disease Sanjay Mehta and David G. McCormack; 18. Current treatment of pulmonary vascular diseases Tarek Saba and Andrew Peacock; 19. Future treatment of pulmonary vascular diseases Norbert F. Voelkel, M. W. Geraci and S. Abman; Part V. Lung Cancer:20. Molecular pathology of lung cancer Ignacio I. Wistuba and Adi F. Gazdar; 21. Small cell lung cancer Desmond N. Carney; Part VI. Cough: 22. Mechanisms of cough John J. Adcock; 23. Current treatment of cough Peter V. Dicpinigaitis.